PAWS* news on topical pain management cream! Details Inside...Sent Thursday, December 5, 2013View as html
NEW PROFILE PAWS Unisource Corp. - $0.0193 cents... Begin your research here: http://pharmacydevelopment.com/ [ http://unisourcecorp.com ] BREAKING NEWS Dec. 5th, 2013 - During November 2013, MESA's sales of its non-narcotic topical pain management creams exceeded $3,600,000, however the Company believes that the recent decision by the FDA to recommend the reclassification of Hydrocodone Combination Products to Schedule II could have profoundly beneficial effects on sales of Mesa Pharmacy, Inc.'s primary products. On October 24 2013, the FDA announced its intention to recommend to the Department of Health and Human Services (HHS) that Hydrocodone Combination Products should be reclassified to a different and more restrictive schedule (From Schedule III to Schedule II, which includes drugs like morphine and oxycodone). The net effect being that hydrocodone combination products could no longer be prescribed over the phone, instead requiring that all prescriptions be in writing and with no more than a three month supply. Read more... [ http://ih.advfn.com/p.php?pid=nmona&article=60278724 ]
PAWS just announced that it intends to begin implementation of its In-Office Dispensing Program (IODP) during the first half of December 2013 through their Advanced Access Pharmacy Services, LLC (AAPS) subsidiary and expects revenues to exceed 50 million in 2014! Read More... [ http://ih.advfn.com/p.php?pid=nmona&article=60164549 ] Pharmacy Development Corp. ("PDC") was established in 2007 to expand the already existing chain of Mesa Pharmacy stores, further expand its pharmacy Compounding practice and continue the production and promotion of its private label whole food supplement line. PDC currently has two operating subsidiaries in Mesa Pharmacy, Inc. ("MPI"), a chain of pharmacies, and Life Genix, Inc ("LGI"), a whole food supplements company. MESA focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and clinics. MESA has developed a series of topical ointments, in different strengths, that provide the pain relief doctors seek. Read More... [ http://ih.advfn.com/p.php?pid=nmona&article=59791820 ] Many physicians are concerned about prescribing oral controlled narcotic pain medication such as Oxycontin or Vicodin to their patients and are looking for an alternative delivery system. Using only FDA approved medications, MESA has developed a series of topical ointments, in different strengths, that provide the pain relief doctors seek. Compounding, where the pharmacist individually mixes the drugs, is a long established tradition in the pharmacy industry. 250 million compounding prescriptions are written each year in the U.S. and in 2009, in California alone, pharmacies were paid $340 million by insurance companies representing employers with injured workers. What is compounding? Compounding is the mixing of drugs by a compounding pharmacist to fit the unique needs of a patient. Mesa Pharmacy provides customized compounds for pain management, bio-identical hormone replacement therapy and much, much more. Mesa Pharmacy produces its custom compounds for pain management therapy and hormone replacement therapy at its Irvine retail pharmacy location. The Irvine facility has the capability of handling thousands of compounding prescriptions per month. Compounding Benefits * Effective for neuropathic pain. * Non-steroidal anti-inflammatory. * Produces a heating sensation that interferes with neurotransmitter. * Stimulates circulation and causes a cool and soothing effect. * Gel based for maximized absorption. Follow the CROWD and quickly put PAWS on your WATCH LIST! http://pennystockcrowd.com Always do your own due diligence... Happy Trading!
No comments:
Post a Comment